Zeljko Reiner Selected Research

Zeljko Reiner Research Topics

Disease

15	Hypertension (High Blood Pressure) 01/2016 - 03/2004
15	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 05/2002
11	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2008
9	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2006
8	Atherosclerosis 01/2021 - 06/2004
6	Coronary Disease (Coronary Heart Disease) 04/2016 - 08/2006
6	Obesity 01/2016 - 11/2008
5	Diabetes Mellitus 03/2014 - 12/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2013 - 11/2008
5	Hypercholesterolemia 10/2010 - 11/2002
4	Inflammation (Inflammations) 10/2010 - 01/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 05/2009
3	Overweight 04/2016 - 03/2011
3	Weight Loss (Weight Reduction) 03/2012 - 05/2009
2	COVID-19 01/2022 - 04/2021
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 03/2014
2	Insulin Resistance 01/2021 - 09/2013
2	Infections 10/2019 - 01/2007
2	Acute Coronary Syndrome 04/2016 - 01/2004
2	Stroke (Strokes) 10/2015 - 05/2010
2	Muscular Diseases (Myopathy) 08/2013 - 06/2011
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2013 - 01/2007
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2010 - 01/2006
2	Hypertriglyceridemia 01/2006 - 11/2002
1	Disease Progression 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2021
1	Bacterial Infections (Bacterial Infection) 10/2019
1	Sepsis (Septicemia) 10/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Ischemic Stroke 10/2015
1	Psoas Abscess 08/2015
1	Gaucher Disease (Gaucher's Disease) 05/2014
1	Fabry Disease (Fabry's Disease) 05/2014
1	Kidney Diseases (Kidney Disease) 03/2014
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 08/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2013
1	Heart Diseases (Heart Disease) 01/2013
1	Glucose Intolerance 12/2012
1	Abdominal Obesity 12/2012
1	Deglutition Disorders (Dysphagia) 09/2011
1	Ulcer 09/2011
1	Dementia (Dementias) 09/2011

Drug/Important Bio-Agent (IBA)

18	HDL CholesterolIBA 01/2022 - 11/2002
18	LDL CholesterolIBA 01/2022 - 11/2002
14	Triglycerides (Triacylglycerol)IBA 01/2021 - 06/2004
12	LipidsIBA 01/2022 - 11/2002
11	CholesterolIBA 01/2022 - 11/2002
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2004
7	Lipoproteins (Lipoprotein)IBA 01/2022 - 05/2002
6	HDL LipoproteinsIBA 01/2016 - 11/2002
5	oxidized low density lipoproteinIBA 01/2022 - 01/2006
5	LDL Lipoproteins (beta Lipoproteins)IBA 11/2008 - 11/2002
4	EnzymesIBA 05/2014 - 03/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2015
3	Pharmaceutical PreparationsIBA 10/2015 - 12/2005
3	Blood Glucose (Blood Sugar)IBA 09/2013 - 03/2011
3	Biomarkers (Surrogate Marker)IBA 04/2012 - 10/2010
3	ApolipoproteinsIBA 11/2008 - 11/2002
2	Biological ProductsIBA 04/2021 - 10/2010
2	Apolipoproteins B (ApoB)IBA 01/2013 - 06/2004
2	CollagenIBA 03/2011 - 01/2004
2	Apoprotein(a) (Apolipoprotein (a))IBA 12/2010 - 06/2004
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2010 - 08/2006
2	SaltsIBA 05/2010 - 03/2009
2	Lipoprotein(a)IBA 03/2010 - 11/2002
2	Interleukin-6 (Interleukin 6)IBA 10/2009 - 01/2007
2	Dietary Sodium Chloride (Table Salt)IBA 05/2009 - 05/2009
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	Insulin (Novolin)FDA Link 01/2021
1	MelatoninIBA 01/2021
1	Fenofibrate (CiL)FDA LinkGeneric 01/2021
1	red yeast riceIBA 01/2021
1	Proprotein Convertase 9IBA 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019
1	lipoprotein cholesterolIBA 01/2019
1	AnticoagulantsIBA 10/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2015
1	Antihypertensive Agents (Antihypertensives)IBA 10/2015
1	Glucosylceramidase (Glucocerebrosidase)IBA 05/2014
1	Hemoglobins (Hemoglobin)IBA 03/2014
1	SolutionsIBA 12/2013
1	VaccinesIBA 12/2013
1	Genetic Markers (Genetic Marker)IBA 09/2013
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 09/2013
1	PPAR gammaIBA 09/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2013
1	Transfer RNA (tRNA)IBA 08/2013
1	Trp Transfer RNA (tRNA(Trp))IBA 08/2013
1	Tryptophan (L-Tryptophan)FDA Link 08/2013
1	SugarsIBA 03/2012
1	FructoseIBA 03/2012
1	Trans Fatty AcidsIBA 03/2012

Therapy/Procedure

8	Therapeutics 01/2021 - 05/2002
3	Secondary Prevention 04/2016 - 08/2006
3	Renal Dialysis (Hemodialysis) 01/2006 - 05/2002
2	Drug Therapy (Chemotherapy) 12/2012 - 11/2008
1	Percutaneous Coronary Intervention 04/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2016
1	Laparotomy 08/2015
1	Parenteral Nutrition 09/2011